Nivel de capacitación
Level 1 = This fundamental material is intended for a broad audience of learners, of multiple cadres, who may provide care for patients with severe or critical illness, but may have little or no experience caring for severe or critically-ill patients and are usually not the primary decision maker for guiding care.
Level 2 = This intermediate material is intended for a more advanced audience of learners than level 1, with some experience caring for patients with severe or critical illness, and may not be essential for all practitioners who provide this level of care.
Level 3 = This advanced material is intended for an audience with significant experience caring for patients with severe and critical illness, including those who guide care decisions these patients.
Nuevo: COVID-19 Prueba-para-tratar algoritmo para antivirales orales ambulatorios
Descargar
Recursos
Por favor utilice la búsqueda o los filtros a continuación para encontrar lo que necesita.
Resultados:
Ordenar por:
Information for clinicians on mechanism of action for Molnupiravir, contraindications & indications, general dosage guidelines
Information for clinicians on mechanism of action for Paxlovid, contraindications & indications, general dosage guidelines.
Brief overview of the Test-to-Treat activity, answers key questions on purpose and target population
Information on purpose and use of self-tests in various environments.
Check out our OCC Job Aid Builder Tool for more free content to make your own job aid. Topics include respiratory care, emergency algorithms, critical care medications, procedures with more topics and more languages coming soon.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Two-page information sheet designed for patients who are taking molnupiravir. It is intended to be printed double-sided and folded in half.
Two-page information sheet designed for patients who are taking Paxlovid. It is intended to be printed double-sided and folded in half